Amphastar Pharmaceuticals, Inc.
AMPH
Revenue
182.39M
▲10.56M▲6.14%
3 Months ChangeAssets
1.49B
▼-82.80M▼-5.26%
3 Months ChangeLiabilities
778.18M
▼-123.79M▼-13.72%
3 Months ChangeFree Cash Flow
46.50M
▲15.59M▲50.45%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-30
Form 8-K
ID: 0001297184-24-000051
2024-08-09
Form 10-Q
ID: 0001297184-24-000048
2024-08-07
Form 8-K
ID: 0001297184-24-000045
2024-06-04
Form 8-K
ID: 0001297184-24-000042
2024-05-10
Form 10-Q
ID: 0001297184-24-000037
2024-05-08
Form 8-K
ID: 0001297184-24-000033
2024-02-28
Form 8-K
ID: 0001297184-24-000004
2023-11-08
Form 10-Q
ID: 0001297184-23-000082
2023-11-08
Form 8-K
ID: 0001297184-23-000079
2023-09-15
Form 8-K
ID: 0001297184-23-000074